Lecap Asset Management Ltd. Has $2.88 Million Position in Bath & Body Works, Inc. (NYSE:BBWI)

Lecap Asset Management Ltd. cut its position in Bath & Body Works, Inc. (NYSE:BBWI) by 38.5% in the 4th quarter, HoldingsChannel.com reports. The firm owned 74,284 shares of the company’s stock after selling 46,579 shares during the period. Bath & Body Works comprises about 0.8% of Lecap Asset Management Ltd.’s portfolio, making the stock its 25th biggest holding. Lecap Asset Management Ltd.’s holdings in Bath & Body Works were worth $2,880,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in BBWI. True Wealth Design LLC boosted its position in shares of Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after acquiring an additional 1,054 shares during the period. UMB Bank n.a. raised its stake in Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock worth $35,000 after purchasing an additional 335 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its stake in Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after purchasing an additional 900 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new stake in Bath & Body Works in the 3rd quarter valued at about $39,000. Finally, TD Private Client Wealth LLC grew its position in shares of Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Trading Down 3.5 %

Bath & Body Works stock opened at $37.41 on Friday. The company has a market capitalization of $8.10 billion, a PE ratio of 9.12, a P/E/G ratio of 1.01 and a beta of 1.83. The stock has a 50-day moving average price of $37.75 and a two-hundred day moving average price of $33.67. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same period last year, the company earned $0.48 EPS. The firm’s revenue was up 3.1% compared to the same quarter last year. As a group, analysts predict that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Analysts Set New Price Targets

BBWI has been the subject of several recent research reports. TD Cowen boosted their price target on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Deutsche Bank Aktiengesellschaft increased their target price on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Morgan Stanley dropped their price target on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. Wells Fargo & Company upgraded shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $42.00 to $48.00 in a research note on Friday, January 10th. Finally, Telsey Advisory Group restated an “outperform” rating and issued a $42.00 target price on shares of Bath & Body Works in a research report on Monday, November 25th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $43.19.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.